Last updated: August 1, 2024
Sponsor: Copenhagen University Hospital at Herlev
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
Whole exome sequencing
Clinical Study ID
NCT05736237
H-20027930
Ages 18-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adult patients over the age of 18, who are capable of giving consent
Diagnosis of optic disc drusen and a minimum of 3 optic disc drusen-affected familymembers
Exclusion
Exclusion Criteria:
Less than 3 affected family members
Under the age of 18 or mentally disabled
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Whole exome sequencing
Phase:
Study Start date:
May 01, 2023
Estimated Completion Date:
May 31, 2024
Study Description
Connect with a study center
Department of Ophthalmology
Glostrup, 2600
DenmarkSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.